Molecular descriptors of N-arylhydroxamic acids: A tool in drug design

Chemical Biology and Drug Design

Volumn 68, Issue 4, 2006, Pages 225-228

  Tiwari, Vaishali ^a   Pande, Rama ^a  

^a PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Drug design; Hydrogen bond; Hydroxamic acids; Log P; Molecular descriptors; Steric descriptor

Indexed keywords

HYDROXAMIC ACID;

ACIDITY; ALKALINITY; ARTICLE; DRUG DESIGN; HYDROGEN BOND; LIPOPHILICITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL;

1-OCTANOL; ALGORITHMS; DRUG DESIGN; HYDROGEN BONDING; HYDROPHOBICITY; HYDROXAMIC ACIDS; MODELS, CHEMICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLUBILITY; WATER;

EID: 33751030450     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00433.x     Document Type: Article

References (24)

1. Pliska V., Testa B., van de Waterbeemd H. (1996) Lipophilicity in Drug Action and Toxicology, Vol. 4. Weinheim, Germany: VCH.
2. Lewis D.F., Lake B.G., Dickins M. (2006) Quantitative structure-activity relationships (QSARs) in CYP3A4 inhibitors: the importance of lipophilic character and hydrogen bonding. J Enzyme Inhib Med Chem;21:127-132.
3. Leng Y., Chuang D.M. (2006) Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci;26:7502- 7512.
4. Wischnewski F., Pantel K., Schwarzenbach H. (2006) Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res;4:339-349.
5. Pepeljnjak S., Zorc B., Butula I. (2005) Antimicrobial activity of some hydroxamic acids. Acta Pharm;55:401-408.
6. Pande R., Tandon S.G. (1979) Preparation and properties of N-arylhydroxamic acids. J Chem Eng Data;24:72-74.
7. Agrawal D.R., Tandon S.G. (1972) Preparation and properties of N-arylhydroxamic acids. J Chem Eng Data;17:257-258.
8. Pande R., Tandon S.G. (1979) Spectrophotometric determination of N-p-tolylbenzohydroxamic acid. Z Anal Chem;296:407-408.
9. Wu W., Borch R.F. (2006) Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs. Mol Pharm;3:451-456.
10. Bodor N., Buchwald P. (1997) Molecular size based approach to estimate partition properties of organic solutes. Phys Chem;101:3404-3412.
11. Bondi A. (1964) van der Waals volume and radii. J Phys Chem;68:441-450.
12. Edward T. (1998) Calculation of octanol-water partition coefficient of organic solutes from their molecular volumes. Can J Chem;76:1294-1303.
13. Vanjari H., Pande R. (2003) Hydroxamic acids: proton donor and acceptor strength for use in drug design. J Pharm Biomed Anal;33:783-788.
14. Zissimos A.M., Abraham M.H., Barker M.C., Box K.J., Tam K.Y. (2002) Calculation of Abraham descriptors from solvent-water partition coefficients in four different systems; evaluation of different methods of calculation. J Chem Soc, Perkin Trans;2:470-477.
15. Tiwari V., Pande R. (2006) Volumetric studies and thermodynamics of viscous flow of hydroxamic acids in acetone: water mixed solvent at 303.15 and 313.15 K. Thermochim Acta;443:211-216.
16. Parvez A., Fyfe C.A., Mellors A. (1974) Parachors in drug design. Biochem Pharmacol;24:1103-1109.
17. Bartzatt R. (2005) Applying pattern recognition methods and structure property correlations to determine drug carrier potential of nicotinic acid and analogize to dihydropyridine. Eur J Pharm Biopharm;59:63-71.
18. Parvez A., Fyfe C.A., Mellors A. (1975) Anti-inflammatory steroids, lysosomal stabilization and parachor. Can J Biochem;53:1047-1053.
19. Kubinyi H. (1993) Methods and principles in Medicinal Chemistry. In: Mannhold R., Krogsgaard-Larsen P., Timmerman H., editors. QSAR: Hansch Analysis and Related Approaches. Weinheim and New York: VCH;40 pp.
20. Tiwari V., Pande R. (2006) Excess refraction properties of hydroxamic solutions at 303.15 and 313.15 K. J Mol Liq;128:178-181.
21. Taft R.W., Berthelot M., Laurence C., Leo A.J. (1996) Hydrogen bonds and molecular structure. Chemtech;26:20-29.
22. Leo A.J., Hoekman D. (2000) Calculating log P(oct) with no missing fragments; the problem of estimating new interaction parameters. Perspect Drug Discov Des;18:19-38.
23. Leo A., Hansch C., Elkins D. (1971) Partition coefficients and their uses. Chem Rev;71:525-616.
24. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev;23:4-25.